Genetically engineered mouse models have shown that Kras mutation could faithfully recapitulate the progression of the human cancer, and a mutated form of Kras is sufficient to initiate pancreatic and lung cancer (33, 34). This evidence concerns the gene KRAS and lung carcinoma.